T32 Training Program in Cancer Biology
T32 Training Program in Cancer Biology
批准号:
10714463
负责人:
David Sung-wen Yu
金额:
$16.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Advances in our understanding of the biology of cancer have the potential to lead to significant breakthroughs in
cancer diagnosis and treatment; however, the translation of basic science discoveries to clinical advancement
has been impaired by the dichotomous training of basic scientists and clinicians. Thus, there is a compelling
need for an enhanced mentored research training program that will bridge the gap between training in rigorous
scientific investigation following the scientific method and compassionate clinical care for the patient. We propose
a Training Program in Cancer Biology that will take advantage of the outstanding resources, high caliber of
investigators, and close collaboration between cancer biologists and clinicians at the Winship Cancer Institute of
Emory University, Georgia’s first and only NCI-designated comprehensive cancer center, to provide a unique,
individualized, and multi-faceted training experience to support the development of postdoctoral trainees in
acquiring the knowledge and skills to address the most important biological questions and clinically significant
problems so that they can make transformative discoveries to improve quality of care for patients with cancer.
The objective of the Emory Training Program in Cancer Biology is to provide postdoctoral trainees with the
infrastructure, resources, training, experience, and mentorship to acquire the depth of knowledge and critical
skills in cancer biology research combined with the practical exposure and understanding of clinical concepts to
initiate an impactful independent research program that will translate novel insights in cancer biology into
improvements in clinical care. Aims of the training program include: 1) Organized research training, 2)
Comprehensive formal and informal didactics, 3) Clinical exposure through tumor boards and clinics, 4) Career
development activities, and 5) Plan for transition to independence. The program will train two new postdoctoral
trainees in the first year followed by an additional two trainees in the second year for a total of four trainees per
year by the second year. Postdoctoral trainees will be rigorously selected from an exceptionally strong and broad
applicant pool of PhD and/or MDs within the first two years of their postdoctoral training and will complete 12-24
months of full-time mentored research. Trainees will have the opportunity to engage in independent research in
the labs of a multidisciplinary group of 22 well-funded and experienced Mentors and junior Mentors paired with
a senior co-Mentor from 10 basic science and clinical departments who are all full members of three
complementary and synergistic research programs of the Winship Cancer Institute: 1) Cell and Molecular Biology,
2) Cancer Immunology, and 3) Discovery and Developmental Therapeutics. All trainees will be required to form
a Mentoring Committee with at least one clinical mentor. Outstanding institutional commitment and focus on
inclusive excellence includes support for an additional postdoctoral trainee position per year for the recruitment
of an underrepresented trainee, salary support for the PI, administrators, and trainees, and Office of Postdoctoral
Education resources. This program intends to train the next generation of cancer scientific leaders.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.
免疫治疗每日输注时间对转移性肾细胞癌患者生存和免疫相关性的影响:多中心队列分析。
DOI:
10.1136/jitc-2023-008011
发表时间:
2024
期刊:
Journal for immunotherapy of cancer
影响因子:
10.9
作者:
[Patel,JimmyS, Woo,Yena, Draper,Amber, Jansen,CarolineS, Carlisle,JenniferW, Innominato,PasqualeF, Lévi,FrancisA, Dhabaan,Layla, Master,VirajA, Bilen,MehmetA, Khan,MohammadK, Lowe,MichaelC, Kissick,Haydn, Buchwald,ZacharyS, Qian,Da]
通讯作者:
Qian,Da
P3: Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint BlockadeýSUBAWARD
-
批准号:10704715
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2022
-
负责人:David Sung-wen Yu
-
依托单位:
P3: Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint BlockadeýSUBAWARD
-
批准号:10526305
-
项目类别:
-
资助金额:$23.64万
-
财政年份:2022
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the DNA Damage Response
-
批准号:10433994
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the Replication Stress Response
-
批准号:8766965
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the Replication Stress Response
-
批准号:8701259
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the Replication Stress Response
-
批准号:9110215
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the Replication Stress Response
-
批准号:8841506
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the DNA Damage Response
-
批准号:9978732
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the Replication Stress Response
-
批准号:8562313
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the Replication Stress Response
-
批准号:9090220
-
项目类别:
-
资助金额:$7.49万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the DNA Damage Response
-
批准号:10653826
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Mechanisms of SIRT2 Function in the DNA Damage Response
-
批准号:10208792
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2013
-
负责人:David Sung-wen Yu
-
依托单位:
Role of CDK9 in the Replication Stress Response
-
批准号:8494591
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2010
-
负责人:David Sung-wen Yu
-
依托单位:
Role of CDK9 in the Replication Stress Response
-
批准号:7773695
-
项目类别:
-
资助金额:$0.71万
-
财政年份:2010
-
负责人:David Sung-wen Yu
-
依托单位:
Role of CDK9 in the Replication Stress Response
-
批准号:8326198
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2010
-
负责人:David Sung-wen Yu
-
依托单位:
Role of CDK9 in the Replication Stress Response
-
批准号:8195284
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2010
-
负责人:David Sung-wen Yu
-
依托单位:
Role of CDK9 in the Replication Stress Response
-
批准号:8088123
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2010
-
负责人:David Sung-wen Yu
-
依托单位:
海外基金